- Home
- CLRB vs USEA Comparison
CLRB vs USEA Comparison
Compare CLRB & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- USEA
- Stock Information
- Founded
- CLRB 2002
- USEA 2004
- Country
- CLRB United States
- USEA Greece
- Employees
- CLRB N/A
- USEA N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- CLRB Health Care
- USEA Consumer Discretionary
- Exchange
- CLRB Nasdaq
- USEA Nasdaq
- Market Cap
- CLRB 17.5M
- USEA 15.6M
- IPO Year
- CLRB N/A
- USEA N/A
- Fundamental
- Price
- CLRB $4.97
- USEA $1.66
- Analyst Decision
- CLRB Hold
- USEA
- Analyst Count
- CLRB 2
- USEA 0
- Target Price
- CLRB N/A
- USEA N/A
- AVG Volume (30 Days)
- CLRB 110.6K
- USEA 20.8K
- Earning Date
- CLRB 11-17-2025
- USEA 11-25-2025
- Dividend Yield
- CLRB N/A
- USEA 2.41%
- EPS Growth
- CLRB N/A
- USEA N/A
- EPS
- CLRB N/A
- USEA N/A
- Revenue
- CLRB N/A
- USEA $42,625,000.00
- Revenue This Year
- CLRB N/A
- USEA N/A
- Revenue Next Year
- CLRB N/A
- USEA N/A
- P/E Ratio
- CLRB N/A
- USEA N/A
- Revenue Growth
- CLRB N/A
- USEA N/A
- 52 Week Low
- CLRB $4.11
- USEA $1.00
- 52 Week High
- CLRB $66.00
- USEA $2.52
- Technical
- Relative Strength Index (RSI)
- CLRB 45.44
- USEA 48.82
- Support Level
- CLRB $4.56
- USEA $1.61
- Resistance Level
- CLRB $4.98
- USEA $1.75
- Average True Range (ATR)
- CLRB 0.35
- USEA 0.06
- MACD
- CLRB -0.13
- USEA -0.01
- Stochastic Oscillator
- CLRB 18.11
- USEA 43.71
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About USEA United Maritime Corporation
United Maritime Corp is an international shipping company. It is engaged in seaborne transportation services. The group currently operates a fleet of seven dry bulk vessels, comprising three Panamax, two Capesize and two Kamsarmax vessels with an aggregate cargo-carrying capacity of approximately 750,758 dwt.